These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 68083)

  • 21. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 22. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation.
    McHugh YH; Bonavida B
    Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
    Kaneko Y; Natsuume-Sakai S; Migita S
    J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 32. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
    Nakayama E; Uenaka A; Stockert E; Obata Y
    Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship of tumor immunity to main histocompatibility complex: possible role for viral-associated murine self antigens in cell-mediated immunity.
    Shearer GM
    Transplant Proc; 1977 Mar; 9(1):853-7. PubMed ID: 325818
    [No Abstract]   [Full Text] [Related]  

  • 38. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice.
    Lord EM; Nardella G
    Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.